Search for: "CUBIST PHARMACEUTICALS LLC"
Results 1 - 13
of 13
Sorted by Relevance
|
Sort by Date
24 Jan 2018, 6:19 am
Skeletal Formula of Daptomycin Author Fvasconcellos Licence copyright waived by the author Wikipedia Jane Lambert Court of Appeal (Lord Justices Lewison and Kitchin) Hospira UK Ltd v Cubist Pharmaceuticals LLC [2018] EWCA Civ 12 (18 Jan 2018) Daptomycin is an antibiotic used to treat systemic and life-threatening infections caused by multiple drug [read post]
11 Oct 2018, 3:01 pm
More from our authors: International Licensing Agreements: IP, Technology Transfer and Competition Law by Michala Meiselles, Hugo Wharton € 180 The Law of the European Union, Fifth Edition by eter Jan Kuijper, Fabian Amtenbrink, Deirdre Curtin, Bruno De Witte, Alison McDonnell, Stefaan van den Bogaert € 175 The post United Kingdom:… [read post]
31 Jul 2014, 8:43 pm
Cubist Pharmaceuticals Inc. v. [read post]
30 Aug 2016, 7:52 am
This judgment [Hospira UK Ltd v Cubist Pharmaceuticals LLC [2016] EWHC 1285 (Pat) (10 June 2016)] was handed down a little while ago, but this Kat only recently got round to studying it properly, containing as it does decisions relating to three rather different patents. [read post]
10 Jun 2010, 3:58 am
APP Pharmaceuticals LLC et al. [read post]
18 May 2016, 8:19 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
16 Jun 2010, 3:02 pm
Stamatios Mouratidis (TTABlog) US: Multiple rejections during prosecution undermine plaintiff’s bid for preliminary injunction: Graceway Pharmaceuticals, LLC et al v. [read post]
3 Jun 2016, 6:40 am
Nova Chemicals Corporation (Canada), et al., No. 15-1160 (standard for appellate review of jury verdict of definiteness that is inherently based upon the jury’s factual findings) [DowPetition] Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 9:58 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 May 2016, 1:42 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
28 Jun 2016, 6:41 am
Nova Chemicals Corporation (Canada), et al., No. 15-1160 (standard for appellate review of jury verdict of definiteness that is inherently based upon the jury’s factual findings) [DowPetition] Cubist Pharmaceuticals, Inc. v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
